Escaping the catch 22 of lupus anticoagulant testing
High-risk patients with antiphospholipid syndrome (APS) experience increased risk of thrombosis when treated with direct oral anticoagulant (DOAC) therapy compared with warfarin. It is essential to establish the APS diagnosis to choose therapy and determine treatment duration. It requires testing fo...
Saved in:
| Main Authors: | Søren Andreas Just, Pernille Just Vinholt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/6/1/e001156.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Catch-22 Situation with Unexpected Reports in Acute Lymphoblastic Leukemia
by: Swetha Palla, et al.
Published: (2025-04-01) -
Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations
by: M Alikaşifoğlu, et al.
Published: (2000-07-01) -
Lupus anticoagulant: a clinical and laboratory diagnostic dilemma
by: Shalini Trivedi, et al.
Published: (2022-03-01) -
Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
by: Laurence S Magder, et al.
Published: (2020-10-01) -
Assessment of the risk of road embankment instability due to water filtration using fully coupled numerical analysis
by: Miłosz Just
Published: (2025-06-01)